Tohoku J. Exp. Med., 2023 February, 259(2)

[Corrigendum] High Body Mass Index is Correlated with the Success of Vonoprazan-Based Second-Line Therapy for Helicobacter Pylori Infection

Toyotaka Kasai,^1,2 Sho Suzuki,^2,3 Chika Kusano,² Hisatomo Ikehara,² Ryoji Ichijima,² Motoki Ohyauchi,⁴ Masashi Kawamura,⁵ Yoshioki Yoda,⁶ Moriyasu Nakahara,⁷ Koichi Kawabe¹ and Takuji Gotoda²

¹Department of Gastroenterology, Fukaya Red Cross Hospital, Fukaya, Saitama, Japan
²Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
³Department of Gastroenterology, Yuri Kumiai General Hospital, Yurihonjo, Akita, Japan
⁴Department of Gastroenterology, Osaki Citizen Hospital, Osaki, Miyagi, Japan
⁵Department of Gastroenterology, Sendai City Hospital, Sendai, Miyagi, Japan
⁶Yamanashi Koseiren Health Care Center, Kofu, Yamanashi, Japan
⁷Department of Gastroenterology, Chichibu Municipal Hospital, Chichibu, Saitama, Japan

Tohoku J. Exp. Med., 253: 85-94, 2021. doi: 10.1620/tjem.253.85.
In the version of this article published in the February issue, 2021, the author mistook the affiliation of the first author. The correct affiliation of Toyotaka Kasai is Department of Gastroenterology, Fukaya Red Cross Hospital, Fukaya, Saitama, Japan and Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Concerning the “Table 1” (Page 91) of this article, the authors found that the sex item was missing. Table 1 added sex item is the next page. The authors sincerely apologize for the oversight on this matter.

© 2023 Tohoku University Medical Press

===============================

Tohoku J. Exp. Med 2023, 259, 173-174.

Correspondence: Sho Suzuki, M.D., Ph.D., Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8309, Japan.

e-mail: s.sho.salubriter.mail@gmail.com